Tempus AI, Inc. (TEM)
Automate Your Wheel Strategy on TEM
With Tiblio's Option Bot, you can configure your own wheel strategy including TEM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TEM
- Rev/Share 4.7114
- Book/Share 1.9131
- PB 35.7222
- Debt/Equity 2.6296
- CurrentRatio 1.7059
- ROIC -0.5453
- MktCap 11486071233.0
- FreeCF/Share -1.2473
- PFCF -54.0074
- PE -16.4326
- Debt/Assets 0.5558
- DivYield 0
- ROE -5.3065
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | TEM | BTIG Research | -- | Buy | -- | $60 | April 21, 2025 |
| Downgrade | TEM | JP Morgan | Overweight | Neutral | $50 | $55 | Feb. 25, 2025 |
| Downgrade | TEM | William Blair | Outperform | Market Perform | -- | -- | Feb. 12, 2025 |
| Resumed | TEM | TD Cowen | -- | Buy | $58 | $74 | Feb. 5, 2025 |
| Initiation | TEM | Wolfe Research | -- | Outperform | -- | $60 | Dec. 13, 2024 |
| Initiation | TEM | Guggenheim | -- | Buy | -- | $74 | Dec. 9, 2024 |
| Downgrade | TEM | BofA Securities | Buy | Neutral | $45 | $60 | Oct. 2, 2024 |
News
5 stocks Congress is buying in 2025
Published: February 20, 2025 by: Finbold
Sentiment: Neutral
The stock trading activities of US Congress members continue to draw attention, with disclosures under the STOCK Act providing insight into their investment strategies. So, in this piece, we bring you the top 5 stocks Congress is buying in 2025.
Read More
Ares Management Upsizes Tempus Debt Facilities to $560 Million
Published: February 18, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Ares Management Corporation (NYSE: ARES) (“Ares”), a leading global alternative investment manager, announced today that Ares Credit funds served as the administrative agent on $300 million in incremental debt financing for Tempus AI, Inc. (NASDAQ: TEM) (“Tempus”), a technology company leading the adoption of AI to advance precision medicine and patient care. The financing is intended to support Tempus' previously announced acquisition of Ambry Genetics (“Ambry”), whi.
Read More
Tempus AI Is A Buy On Dips In The AI-Driven Healthcare Sector
Published: February 18, 2025 by: Seeking Alpha
Sentiment: Positive
TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics and personalized treatments. Recently, they've made some interesting moves like acquiring Ambry Genetics, launching the Olivia health app, and collaborating with IFLI. TEM also has other innovative assets like xT CDx, xH tests, and enhanced Tempus One that I think position it perfectly for agentic AI diagnostics.
Read More
Conflicting Signals: Tempus AI's Stock Market Rally
Published: February 17, 2025 by: MarketBeat
Sentiment: Positive
Tempus AI NASDAQ: TEM is a leader in precision medicine and artificial intelligence (AI) in the healthcare sector. Tempus AI's stock price has seen an increase, with gains of over 160% in the last month and almost 150% year-to-date, causing investors to surge in interest.
Read More
AI Roundup: 3 Explosive AI-Adjacent Stocks to Watch in 2025
Published: February 11, 2025 by: Schaeffers Research
Sentiment: Positive
Artificial Intelligence (AI) has dominated headlines to start the year, especially after President Donald Trump revealed a joint venture to invest "$500 billion, at least" for AI Infrastructure in the U.S. More recently, Chinese startup DeepSeek shook up the sector after its AI model beat out OpenAi -- at a significantly lower cost.
Read More
Cathie Wood Is Betting Big on These 2 AI Stocks
Published: February 10, 2025 by: 24/7 Wall Street
Sentiment: Positive
Cathie Wood's comeback could continue through the year as most of her Ark Invest funds come roaring back alongside the tech trade.
Read More
About Tempus AI, Inc. (TEM)
- IPO Date 2024-06-14
- Website https://www.tempus.com
- Industry Medical - Healthcare Information Services
- CEO Eric P. Lefkofsky
- Employees 2400